Luke E. Zabotka

Cardiovascular and mortality risk with intravitreal vascular endothelial growth factor inhibitor in patients with diabetic retinopathy.

Miin Roh, Seoyoung C. Kim, E. Patorno, 2022, Ophthalmology. Retina.

Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies

R. Desai, W. Feldman, Kueiyu Joshua Lin, 2022, Journal of Clinical Epidemiology.

Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety

J. Concato, S. Schneeweiss, Shirley V. Wang, 2022, JNCI cancer spectrum.

Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.

J. Concato, S. Schneeweiss, R. Glynn, 2023, JAMA.

Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review

Sharon E. Davis, Joshua C. Smith, N. Shah, 2023, Drug Safety.

Prognostic Factors of COVID‐19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology

C. Rentsch, D. Moga, J. Guo, 2023, Clinical pharmacology and therapeutics.